Abstract 6615: Novel digital pathology tools for exploring role of myeloid cells in modulating next generation immunotherapies
Richard Van Krieken(Lineage Cell Therapeutics (United States)), Jennifer Bordeaux(Lineage Cell Therapeutics (United States)), Brian Bourke-Martin(Lineage Cell Therapeutics (United States)), Lisa Adams(Navidea Biopharmaceuticals (United States)), Naveen Dakappagari(Navidea Biopharmaceuticals (United States)), Emmanuel Pacia, Beiru Chen(Lineage Cell Therapeutics (United States))
Cited by 0
Related Papers
Antibody validation
|BioTechniques|2010|601
Linear Motif Atlas for Phosphorylation-Dependent Signaling
|Science Signaling|2008|465
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma
|Clinical Cancer Research|2018|176
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
|JCI Insight|2018|162
In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis
|American Journal Of Pathology|2010|154